Quick Takeaways
- Streeterville Capital LLC filed SCHEDULE 13G for 20/20 Biolabs, Inc. Common Stock.
- Disclosed ownership: 9.9%.
- Date of event: 25 Feb 2026.
Streeterville Capital LLC - 25 Feb 2026 SCHEDULE 13G Report for 20/20 Biolabs, Inc. Common Stock
- Filing Manager
- Streeterville Capital LLC
- Reporting Manager
- Streeterville Capital LLC
- Security
- 20/20 Biolabs, Inc. Common Stock
- Shares outstanding
- 5,491,717 shares
- Disclosed Ownership
- 543,680 shares
- Ownership
- 9.9%
- Form type
- SCHEDULE 13G
- Filing time
- 25 Feb 2026, 15:10:15 UTC
- Date of event
- 25 Feb 2026
- SEC
- View on sec.gov
Quoteable Key Fact
"Streeterville Capital LLC disclosed 9.9% ownership in 20/20 Biolabs, Inc. Common Stock on 25 Feb 2026."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 25 Feb 2026, 15:10.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Official SEC Source
Backed by Schedule 13D/13G
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original FilingReporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Streeterville Capital LLC | 9.9% | 543,680 | 543,680 | 0 | John Fife | President | |
| Streeterville Management, LLC | 9.9% | 543,680 | 543,680 | 0 | John Fife | President | |
| John M Fife | 9.9% | 543,680 | 543,680 | 0 | John Fife | President |